Helen P. Roper

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.

Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.

Journal: JAMA
Published: April 05, 2022

Cessation of ambulation results in a dramatic loss of trabecular bone density in boys with Duchenne muscular dystrophy (DMD).

Cessation of ambulation results in a dramatic loss of trabecular bone density in boys with Duchenne muscular dystrophy (DMD).

Journal: Bone
Published: August 25, 2021

TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brain.

TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brain.

Journal: Neuropathology and applied neurobiology
Published: December 29, 2020

Preventing Cardiomyopathy in DMD: A Randomized Placebo-Controlled Drug Trial.

Preventing Cardiomyopathy in DMD: A Randomized Placebo-Controlled Drug Trial.

Journal: Neurology. Clinical practice
Published: June 28, 2020

Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant.

Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant.

Journal: European journal of human genetics : EJHG
Published: February 14, 2019

Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.

Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.

Journal: BMJ open
Published: December 22, 2018

A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet.

A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet.

Journal: Clinical pharmacology in drug development
Published: September 13, 2018

Growth, bone health & ambulatory status of boys with DMD treated with daily vs. intermittent oral glucocorticoid regimen.

Growth, bone health & ambulatory status of boys with DMD treated with daily vs. intermittent oral glucocorticoid regimen.

Journal: Bone
Published: April 24, 2018

Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.

Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.

Journal: Acta neuropathologica
Published: May 09, 2017

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.

Journal: Trials
Published: April 06, 2017

Variations in Duchenne muscular dystrophy course in a multi-ethnic UK population: potential influence of socio-economic factors.

Variations in Duchenne muscular dystrophy course in a multi-ethnic UK population: potential influence of socio-economic factors.

Journal: Developmental medicine and child neurology
Published: March 14, 2017

Duchenne muscular dystrophy: the management of scoliosis.

Duchenne muscular dystrophy: the management of scoliosis.

Journal: Journal of spine surgery (Hong Kong)
Published: October 21, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026